Pharma Journalist 8791 posts 0 comments

Atea Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, today announced an updated strategy for AT-527 to address the rapidly evolving SARS-CoV-2 and emerging variants by…
Read More...

Pfizer Inc. announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) trial…
Read More...

Biogen Inc. and TheraPanacea announced that they have entered into a collaboration focused on multiple therapeutic areas in neuroscience, to further build on the companies’ existing…
Read More...

Merck, a leading science and technology company, announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the…
Read More...

Antengene Corporation Limited global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and…
Read More...

AgeX Therapeutics, Inc. a biotechnology company focused on developing therapeutics for human aging and regeneration, announced a research collaboration with the University of…
Read More...

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, and Foghorn Therapeutics Inc. announced a strategic collaboration to create novel oncology medicines…
Read More...

Pfizer Inc. and Arena Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company…
Read More...

SMi Group reports: CTO and Co-Founder of Envisagenics, Martin Akerman discusses the challenges and developments in the RNA industry SMi’s 13th Annual RNA Therapeutics Conference will…
Read More...

Samsung Biologics continues its strategic biopharmaceutical manufacturing collaboration with AstraZeneca. The partnership is based on an expanded deal this year in May 2021 which…
Read More...